S. Ueda et al., IN-VITRO METABOLIC STUDIES OF TACROLIMUS USING PRECISION-CUT RAT AND HUMAN LIVER SLICES, Journal of pharmaceutical and biomedical analysis, 15(3), 1996, pp. 349-357
The objective of this study was to investigate the in-vitro metabolism
of tacrolimus in liver slices from rats and humans. [C-14]Tacrolimus
(2 or 20 mu M) was incubated with precision-cut human and rat liver sl
ices in 12-well plates for up to 12 h. Concentrations of tacrolimus an
d metabolites were determined by high-performance liquid chromatograph
y (HPLC) radiochromatography. The 13-O-demethylated tacrolimus metabol
ite (M-I) was the major oxidative metabolite in both rat and human liv
er slices. The other primary metabolites of tacrolimus (M-II, M-III, a
nd M-IV) were not seen in either species. Unidentified peaks, which el
uted early in the HPLC system, were probably due to secondary or conju
gated metabolites. The eluate had no pharmacological activity. The fin
ding that M-I was the major tacrolimus metabolite in both human and ra
t liver slice preparations is consistent with previous studies of rat
and human liver microsomes.